rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    WGS
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      GeneDx names Everett Cunningham as new chief executive
      15h agoInvesting.comWGS
      GeneDx at Jefferies Global Healthcare Conference: focus on collections
      Nov 17Investing.comWGSJEF
      GeneDx Holdings (WGS) Says Sequencing Guided Care In More Than 60% Of Patients

      GeneDx Holdings (NasdaqGS:WGS) reported new research showing exome and genome sequencing informed clinical management in over 60% of tested patients. The real-world analysis covered more than 300,000 individuals who received GeneDx genomic testing across a broad clinical setting. GeneDx plans to present the findings at the NSGC 2026 Annual Conference, highlighting the clinical impact of its sequencing platform. The large real-world study on actionable exome and genome results is only one...

      Nov 13Yahoo FinanceWGS
      Who Is Paying For GeneDx's Cash Burn?
      Nov 12Yahoo FinanceWGS
      GeneDx (WGS) Stock Looks About Right After Fresh Sales Progress
      Nov 11Yahoo FinanceWGS
      Is GeneDx Holdings (WGS) Undervalued After Third Quarter 2026 Results?

      GeneDx Holdings (WGS) is back in focus after releasing third quarter 2026 results, showing higher revenue alongside a wider net loss and updated guidance that keeps full year revenue expectations unchanged. The latest earnings update has landed in a tough tape for GeneDx Holdings. The share price has fallen about 59% year to date and the 1 year total shareholder return is down roughly 61%. The 3 year total shareholder return is extremely high, pointing to strong earlier gains but fading...

      Nov 11Yahoo FinanceWGS
      Why GeneDx Holdings Stock Just Dropped 16.6%
      Nov 10Yahoo FinanceWGS
      GeneDx Holdings Corp. Q3 2026 Earnings Call Summary
      Nov 10Yahoo FinanceWGS
      Groupon Posts Downbeat Q3 Results, Joins GeneDx Holdings, Qualys And Other Big Stocks Moving Lower In Tue
      Nov 10BenzingaGRPNQLYSWGSDQ
      BTIG cuts GeneDx stock price target on volume growth miss
      Nov 10Investing.comWGS
      GeneDx stock down as Q4 outlook misses consensus (WGS:NASDAQ)
      Nov 10Seeking AlphaWGS
      GeneDx Holdings Corp (WGS) (Q3 2026) Earnings Call Highlights: Revenue Hits $123. ...

      GeneDx Holdings Corp (WGS) delivered 72% adjusted gross margin and $8.6 million in adjusted net income for Q3 2026, while guiding Q4 revenue to at least $135 million despite PAMA headwinds.

      Nov 10Yahoo FinanceWGS
      GeneDx Stock: Q3 Earnings Indicate Transition To Sustained Profitability (NASDAQ:WGS)

      GeneDx is nearing sustained profitability after a Q3 revenue beat. Valuation is slightly above the sector median. See here for an analysis of WGS stock.

      Nov 10Seeking AlphaWGS
      GeneDx: Q3 Earnings Indicate Transition To Sustained Profitability
      Nov 10Seeking AlphaWGS
      GeneDx Q3 Earnings Call Highlights
      Nov 10Yahoo FinanceWGS
      GeneDx Holdings Q3 2026 Earnings Call Transcript
      Nov 9BenzingaWGS
      GeneDx shares tumble on lowered growth targets

      Investing.com -- GeneDx Holdings Corp (NASDAQ:WGS) reported third quarter results that met revenue expectations but cut its full-year growth targets, sending shares down 10.2% in after-hours trading Monday.

      Nov 9Yahoo FinanceWGS
      GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates

      GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of +300.00% and +0.82%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

      Nov 9Yahoo FinanceWGS
      GeneDx faces earnings test as profit target looms tonight
      Nov 9Investing.comWGS
      No Cost Exome Testing Could Be A Game Changer For GeneDx (WGS)

      Mirum Pharmaceuticals recently announced a collaboration with GeneDx Holdings to provide fully sponsored ExomeDx testing and genetic counseling across cholestasis, early-onset cataracts, and PBD-ZSD programs, with no insurance claims filed for eligible patients. This sponsored access could deepen GeneDx Holdings’ reach in rare disease diagnostics by increasing test volumes, clinician touchpoints, and data accrual without adding direct cost for patients. We will now examine how GeneDx...

      Nov 7Yahoo FinanceWGS
      GeneDx and Mirum to provide genetic tests for cholestasis, cataracts or PBD-ZSD
      Nov 6Yahoo FinanceMIRMWGS
      GeneDx partners with Mirum for free genetic testing program
      Nov 5Investing.comMIRMWGS
      GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing
      Nov 5Yahoo FinanceMIRMWGS
      GeneDx Holdings CFO Kevin Feeley sells $363,892 in stock
      Nov 2Investing.comWGS
      GeneDx Holdings And 2 Other Top Healthcare Stocks
      Oct 31Yahoo FinanceWGS
      Did GeneDx Holdings Corp. Insiders Breach their Fiduciary Duties to Shareholders?
      Oct 27MorningstarWGS
      12 Health Care Stocks Moving In Friday's After-Market Session
      Oct 23BenzingaWGS
      GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
      Oct 23Yahoo FinanceWGS
      GeneDx plans to add long-read genome sequencing to portfolio
      Oct 20Investing.comWGS
      GeneDx to Add Long-Read Whole Genome Sequencing to Testing Portfolio
      Oct 20Yahoo FinanceWGS
      GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
      Oct 19Yahoo FinanceWGS
      GeneDx Holdings And 2 Other Top Healthcare Stocks
      Oct 17Yahoo FinanceWGS
      GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
      Oct 7Yahoo FinanceWGS
      GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
      Oct 2Yahoo FinanceWGS
      GeneDx CEO Katherine Stueland sells $1.03m in stock
      Sep 18Investing.comWGS
      GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C

      GAITHERSBURG, Md., September 09, 2026--GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C

      Sep 9Yahoo FinanceWGS
      GeneDx at Wells Fargo healthcare conference: growth and collections in focus
      Sep 8Investing.comWGSWFC
      GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree

      GAITHERSBURG, Md., September 01, 2026--Katherine Stueland, CEO of GeneDx, has been named a 2026 Fierce 50 honoree for Health Equity

      Sep 1Yahoo FinanceWGS
      GeneDx study shows rapid genome sequencing benefits beyond ICUs
      Aug 24Investing.comWGS
      GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s

      GAITHERSBURG, Md., August 24, 2026--GeneDx and Seattle Children’s show hospital-wide rapid genome sequencing accelerates accurate diagnosis and expands access to answers for children.

      Aug 24Yahoo FinanceWGS

      This is the newest page. Registered accounts read further back.